trending Market Intelligence /marketintelligence/en/news-insights/trending/o3BpevLR1YoBwVCN_vSlUA2 content esgSubNav
In This List

Helix BioPharma COO resigns

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Helix BioPharma COO resigns

Helix BioPharma Corp.'s Steve Demas resigned as COO due to personal reasons.